Monoclonal Antibody Facility Research Technician
About the Monoclonal Antibody Facility This service facility is managed by Dr. Stefan Schüchner and Prof. Egon Ogris and provides a custom-designed monoclonal antibody service for the research community (https://www.maxperutzlabs.ac.at/research/facilities/monoclonal-antibody-facility). Many of our antibodies have been licensed to biotech companies, amongst them the world-wide first CRISPR/Cas9 monoclonal antibody. Currently we work on state-of-the-art antibodies against e.g. novel tumor-associated antigens or Sars-CoV-2 proteins.
About the position/ the research project We are seeking a highly motivated research technician, whose main duties will be the realization of monoclonal antibody projects, including the generation of recombinant antigens, immunizations of mice, collection and screening of sera, fusions of splenocytes and establishment of antibody- secreting hybridoma clones, cell culture, ELISA, and Western blotting.
Candidates Successful candidates should • Hold a degree as e.g. “Chemisch-technische/r Assistant/in” , or equivalent • Have practical experience in molecular biology and cell culture techniques • Show high motivation and the ability for self-contained project implementation and execution as well as excellent teamwork skills • A FELASA B certificate (or similar training for the work with mice) is a plus
Application
• A letter of interest, a copy of relevant certificates, a professional CV and the contact details of two references (pdf format) • Should be sent to [email protected] or [email protected] • By July 15th 2021 • This position is available from September 1st 2021
Contact Stefan Schüchner ([email protected] or +43-1-4277 61731) can be contacted for further details about the open position.
MAX PERUTZ LABS A joint venture of Part of Vienna BioCenter (VBC) • Dr.-Bohr-Gasse 9 • 1030 Vienna Tel: +43 1 4277 24001 • [email protected] www.maxperutzlabs.ac.at
About the Max Perutz Labs The Max Perutz Labs are a research institute established by the University of Vienna and the Medical University of Vienna to provide an environment for excellent, internationally recognized research and education in the field of Molecular Biology. Dedicated to a mechanistic understanding of fundamental biomedical processes, scientists at the Max Perutz Labs aim to link breakthroughs in basic research to advances in human health. The Max Perutz Labs are located at the Vienna BioCenter, one of Europe’s hotspots for Life Sciences, and host around 50 research groups, involving more than 450 scientists and staff from 40 nations.
www.maxperutzlabs.ac.at
A joint venture of Part of